ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,350Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 434

$698K Total Retail Price of All Prescriptions

Rank: 17 out of 434

587 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 587 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,210 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 992 643 1 1
HYDROCODONE-ACETAMINOPHEN 851 452 S3 2 4
SIMVASTATIN 705 413 3 2
METFORMIN HCL 587 408 4 7
LEVOTHYROXINE SODIUM 560 390 5 3
LOVASTATIN 465 315 6 10
AMLODIPINE BESYLATE 433 316 7 6
OMEPRAZOLE 420 220 8 5
HYDROCHLOROTHIAZIDE 415 255 9 8
FUROSEMIDE 294 165 10 9
FENOFIBRATE 289 122 11 43
ZOLPIDEM TARTRATE 283 164 12 11
METOPROLOL TARTRATE 281 213 13 12
GABAPENTIN 258 104 14 14
POTASSIUM CHLORIDE 252 153 15 20
ATENOLOL 226 155 16 16
FLUTICASONE PROPIONATE 208 80 17 26
PRAVASTATIN SODIUM 185 149 18 17
IBUPROFEN 180 73 19 56
GLIPIZIDE 161 100 20 37
CARISOPRODOL 153 34 R 21 44
DICLOFENAC SODIUM 152 81 22 92
VENTOLIN HFA 147 91 23 30
CARVEDILOL 146 96 24 24
OXYBUTYNIN CHLORIDE 145 107 25 82
RANITIDINE HCL 137 85 26 31
NAPROXEN 129 101 27 75
NEXIUM 125 38 28 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 89 29 21
WARFARIN SODIUM 121 95 30 18
ALLOPURINOL 118 81 31 25
ATORVASTATIN CALCIUM 114 95 32 19
TRAMADOL HCL 105 39 33 28
CLOPIDOGREL 100 75 34 41
LANTUS SOLOSTAR 99 54 35 71
ALENDRONATE SODIUM 96 79 36 15
ADVAIR DISKUS 92 36 37 52
LOSARTAN POTASSIUM 88 51 38 13
PAROXETINE HCL 88 47 38 61
PROAIR HFA 84 58 40 60
FAMOTIDINE 84 46 40 76
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 64 42 96
SPIRONOLACTONE 80 36 43 70
CITALOPRAM HBR 80 44 43 23
TIZANIDINE HCL 79 58 45 88
PLAVIX 75 56 46 64
PEN NEEDLE 75 37 46 83
TAMSULOSIN HCL 72 56 48 29
METFORMIN HCL ER 71 46 49 48
TERAZOSIN HCL 70 62 50 40
GLYBURIDE 70 41 R 50 51
ISOSORBIDE MONONITRATE ER 69 36 52 68
SERTRALINE HCL 67 33 53 27
CEPHALEXIN 66 41 54 119
MELOXICAM 61 57 55 46
OXYCODONE HCL 56 29 S2 56 34
PROPRANOLOL HCL 56 0 56 102
TRIAMTERENE-HCTZ 54 44 58 47
CLOTRIMAZOLE-BETAMETHASONE 54 36 58 124
CLONIDINE HCL 54 51 58 63
GLIMEPIRIDE 53 31 61 58
CARTIA XT 53 43 61 167
OXYCODONE-ACETAMINOPHEN 52 23 S2 63 74
CRESTOR 50 22 64 84
KLOR-CON 10 50 22 64 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.